AtriCure Inc
NASDAQ:ATRC
AtriCure Inc
Cash from Operating Activities
AtriCure Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AtriCure Inc
NASDAQ:ATRC
|
Cash from Operating Activities
$4.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is AtriCure Inc's Cash from Operating Activities?
Cash from Operating Activities
4.5m
USD
Based on the financial report for Mar 31, 2024, AtriCure Inc's Cash from Operating Activities amounts to 4.5m USD.